Jonathan Kearsey is the Managing Director and co-founder of Leads To Development (L2D), a drug development consultancy established in 2009. With over 25 years of experience, he has guided numerous early-stage research projects into formal preclinical and clinical development. His expertise covers a range of drug development areas, including small molecules, biological products, and cell therapies. Jonathan earned a doctorate in oncology from the University of London and completed a post-doctoral fellowship at Oxford University. He then spent nearly a decade overseeing the development of oncology products for biotech companies in France and Belgium, gaining substantial drug development and regulatory experience. Under his leadership, L2D has supported the development of over 170 projects, from target discovery to market launch, demonstrating Jonathan’s in-depth understanding of the entire drug development and regulatory landscape.